Jump to content

Sarah Tabrizi

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by LittleWink (talk | contribs) at 18:25, 10 October 2016 (Disambiguating links to Edward Wild (link changed to Edward Wild (neuroscientist)) using DisamAssist.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Prof Sarah Joanna Tabrizi
FMedSci
Sarah Tabrizi in 2013
Sarah Tabrizi in 2013
Known forResearch into neurodegeneration, particularly Huntington's disease
SpouseMichael Nath
AwardsFellowship of the Academy of Medical Sciences, 2014
Scientific career
FieldsNeuroscience
InstitutionsUCL Institute of Neurology;
National Hospital for Neurology and Neurosurgery
Notable studentsEdward Wild
Websitehdresearch.ucl.ac.uk

Sarah Tabrizi FMedSci is a British neurologist and neuroscientist in the field of neurodegeneration, particularly Huntington's disease. She is a Professor at UCL Institute of Neurology; the founder and director of UCL Huntington's Disease Centre; and an Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London, where she established the Multidisciplinary Huntington's Disease Clinic.[1][2][3]

Education

Tabrizi studied biochemistry at Heriot-Watt University followed by medicine at Edinburgh University. She obtained a PhD at University College London in 2000.[4]

Research

Tabrizi is distinguished for her work on Huntington's disease pathobiology, biomarkers, outcome measures and clinical trials.[5][6] She led the influential multi-site TRACK-HD cohort study of Huntington's disease that established a battery of clinical trial outcome measures.[5] She is the lead Clinical Investigator for the first clinical trial of a 'gene silencing' or huntingtin-lowering drug in Huntington's disease patients.[7] Tabrizi gave a keynote presentation at the 2016 Google Zeitgeist Minds conference about the trial, and the prospect of gene silencing for neurodegenerative disease.[8]

As of June 2016, Tabrizi had authored over 300 peer-reviewed publications, 28 of which had over 100 citations.[9]

Awards and honours

Personal life

Tabrizi lives in London with her husband, the author Michael Nath.[4]

References

  1. ^ "Iris View Profile". IRIS - UCL. Retrieved 5 May 2016.
  2. ^ "UCL Huntington's Disease Research". hdresearch.ucl.ac.uk.
  3. ^ "Prof Sarah Tabrizi". www.uclh.nhs.uk.
  4. ^ a b c "Who's Who 2016 - Tabrizi, Prof. Sarah Joanna". Who's Who 2016. Retrieved 6 May 2016.
  5. ^ a b Shetty, Priya (June 2012). "Sarah Tabrizi: tracking Huntington's disease". The Lancet. 379 (9831): 2043. doi:10.1016/S0140-6736(12)60884-8.
  6. ^ Mohammadi, Dara (July 2015). "Fast-forwarding treatment for neurodegenerative disorders". The Lancet Neurology. 14 (7): 687–688. doi:10.1016/S1474-4422(15)00110-6.
  7. ^ Gallagher, James. "Landmark Huntington's trial starts". BBC News. BBC News. Retrieved 5 May 2016.
  8. ^ "Sarah Tabrizi - The Human Revolution". Zeitgeist Minds.
  9. ^ "Sarah J Tabrizi - Google Scholar Citations". scholar.google.co.uk.
  10. ^ "Fellow - Academy of Medical Sciences". www.acmedsci.ac.uk.
  11. ^ "Governance - Wellcome". wellcome.ac.uk.
  12. ^ "Journal of Huntington's Disease". www.iospress.nl. Retrieved 13 June 2016.


Stub icon

This United Kingdom biographical article related to medicine is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Sarah_Tabrizi&oldid=743684689"